Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding

Tekijä Braide, K., Kindblom, J., Lindencrona, U., Hugosson, J., Pettersson, N.
Julkaisussa Clin Transl Oncol (2020)

Editorial Comment: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Tekijä Hugosson, J, Roobol, MJ, Månsson, M, Tammela, TLJ, Zappa, M, Nelen, V, Lott, Felipe
Julkaisussa Int Braz J Urol (2020)

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

Tekijä Wever, E M, Hugosson, J, Heijnsdijk, E A M, Bangma, C H, Draisma, G, de Koning, H J
Julkaistu 2012

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

Tekijä Stranne, J., Axen, E., Franck-Lissbrant, I., Fransson, P., Frånlund, M., Hugosson, J., Khatami, A., Koss-Modig, K., Lodding, P., Nyberg, M., Stattin, P., Bratt, O.
Julkaisussa World J Urol (2019)

Quality-of-life effects of prostate-specific antigen screening

Tekijä Heijnsdijk, EAM, Wever, EM, Auvinen, A, Hugosson, J, Ciatto, S, Nelen, V, Kwiatkowski, M, Villers, A, Páez, A, Moss, SM, Zappa, M, Tammela, TLJ, Mäkinen, T, Carlsson, S, Korfage, IJ, Essink-Bot, ML, Otto, SJ, Draisma, G, Bangma, CH, Roobol, MJ, Schröder, FH, de Koning, HJ
Julkaisussa N Engl J Med (2012)

Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data

Tekijä Heijnsdijk, E. A. M., de Carvalho, T. M., Auvinen, A., Zappa, M., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., Tammela, T. L. J., Recker, F., Denis, L., Carlsson, S.V., Wever, E. M., Bangma, C. H., Schröder, F. H., Roobol, M. J., Hugosson, J., de Koning, H. J.
Julkaisussa J Natl Cancer Inst (2014)

Prostate Cancer Mortality at 11 years of Follow-up in the ERSPC

Tekijä Schröder, FH, Hugosson, J, Roobol, MJ, Tammela, TLJ, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, Denis, LJ, Recker, F, Páez, A, Määttänen, L, Bangma, CH, Aus, G, Carlsson, S, Villers, A, Rebillard, X, Van der Kwast, Th, Kujala, PM, Blijenberg, BG, Stenman, UH, Huber, A, Taari, K, Hakama, M, Moss, SM, de Koning, HJ, Auvinen, A
Julkaisussa N Engl J Med (2012)

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Tekijä FitzGerald, L. M., Zhao, S., Leonardson, A., Geybels, M. S., Kolb, S., Lin, D. W., Wright, J. L., Eeles, R., Kote-Jarai, Z., Govindasami, K., Giles, G. G., Southey, M. C., Schleutker, J., Tammela, T. L., Sipeky, C., Penney, K. L., Stampfer, M. J., Gronberg, H., Wiklund, F., Stattin, P., Hugosson, J., Karyadi, D. M., Ostrander, E. A., Feng, Z., Stanford, J. L.
Julkaisussa Prostate Cancer Prostatic Dis (2018)